JW (Cayman) Therapeutics Co. Ltd
JWCTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $489 | $780 | $1,425 | $5,053 |
| - Cash | $757 | $1,006 | $1,383 | $1,834 |
| + Debt | $422 | $319 | $279 | $147 |
| Enterprise Value | $154 | $93 | $321 | $3,366 |
| Revenue | $158 | $174 | $146 | $31 |
| % Growth | -9% | 19.3% | 373.1% | – |
| Gross Profit | $77 | $88 | $59 | $9 |
| % Margin | 48.9% | 50.7% | 40.3% | 29.4% |
| EBITDA | -$489 | -$656 | -$752 | -$739 |
| % Margin | -308.9% | -377.2% | -516.3% | -2,398.6% |
| Net Income | -$591 | -$768 | -$846 | -$702 |
| % Margin | -373.3% | -441.7% | -580.7% | -2,280.5% |
| EPS Diluted | -1.43 | -1.87 | -2.06 | -1.76 |
| % Growth | 23.5% | 9.2% | -17% | – |
| Operating Cash Flow | -$333 | -$398 | -$537 | -$561 |
| Capital Expenditures | -$15 | -$15 | -$77 | -$73 |
| Free Cash Flow | -$349 | -$413 | -$614 | -$634 |